|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||
|
||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s4DAFDF54-3B4D-11EF-AA85-980D85CE164B&I=39IZM&T=&OP=Display&O=html&O1=12881533&O2=4570000000000332&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3D18F-FDG%2520PET%252FCT%2520Predicts%2520Response%2520to%2520HER2-directed%2520Neoadjuvant%2520Therapy%26rft.au%3DDiwanji%252C%2520Devan%26rft.au%3DHylton%252C%2520Nola%26rft.au%3DRay%252C%2520Kimberly%26rft.date%3D2021-09-17%26rft.eissn%3D2638-616X%26rft.epage%3De219021%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issue%3D5%26rft.jtitle%3DRadiology.%2520Imaging%2520cancer%26rft.spage%3De219021%26rft.volume%3D3%26rft_id%3Dinfo%253Adoi%252F10.1148%252Frycan.2021219021%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-UNPAYWALL-getFullTxt-object,2-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,3-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,4-COBIB_SI_LCL-getHolding-object,5-DOI-getDOI-object,6-REFWORKS_EXPORT_TOOL-getReference-object,7-GOOGLE_SCHOLAR_FREE-getWebSearch-object,8-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.348142&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12881533-s4DAFDF54-3B4D-11EF-AA85-980D85CE164B" timestamp="2024-07-06T06:07:48Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:4570000000000332</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy</jnl:atitle>
<jnl:jtitle>Radiology. Imaging cancer</jnl:jtitle>
<jnl:date>2021-09-01</jnl:date>
<jnl:spage>e219021</jnl:spage>
<jnl:epage>e219021</jnl:epage>
<jnl:issn>2638-616X</jnl:issn>
<jnl:volume>3</jnl:volume>
<jnl:issue>5</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2638-616X</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:338be1a6bb13639e14f6f1716bca5a9558ee3f46</ctx:identifier>
<ctx:identifier>urn:UUID:s4DAFDF54-3B4D-11EF-AA85-980D85CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)